1. Home
  2. HTZ vs COLL Comparison

HTZ vs COLL Comparison

Compare HTZ & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hertz Global Holdings Inc

HTZ

Hertz Global Holdings Inc

HOLD

Current Price

$4.49

Market Cap

1.2B

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$31.96

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTZ
COLL
Founded
1918
2002
Country
United States
United States
Employees
26000
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
HTZ
COLL
Price
$4.49
$31.96
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$4.93
$51.17
AVG Volume (30 Days)
5.7M
538.0K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.73
Revenue
N/A
$780,567,000.00
Revenue This Year
$4.97
$5.93
Revenue Next Year
$3.67
N/A
P/E Ratio
N/A
$18.73
Revenue Growth
N/A
23.62
52 Week Low
$3.50
$23.23
52 Week High
$9.39
$50.79

Technical Indicators

Market Signals
Indicator
HTZ
COLL
Relative Strength Index (RSI) 51.68 23.00
Support Level $3.78 $31.01
Resistance Level $5.47 $32.92
Average True Range (ATR) 0.28 1.31
MACD 0.10 -0.06
Stochastic Oscillator 52.29 0.29

Price Performance

Historical Comparison
HTZ
COLL

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through its Hertz, Dollar and Thrifty brands. The company has two reportable segments: i) Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean, ii) International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The company maintains a substantial network of company-operated rental locations, a majority of which are in Europe, and has franchisees and partners that operate rental locations under brands. Geographical markets include North America, Europe, Pacific Asia, Middle East and Africa, and Latin America.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: